Drägerwerk AG & Co. KGaA (pref) (DRW3) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.037x

Based on the latest financial reports, Drägerwerk AG & Co. KGaA (pref) (DRW3) has a cash flow conversion efficiency ratio of 0.037x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€62.00 Million ≈ $72.49 Million USD) by net assets (€1.66 Billion ≈ $1.94 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Drägerwerk AG & Co. KGaA (pref) worth for the company's overall valuation and market capitalisation.

Drägerwerk AG & Co. KGaA (pref) - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Drägerwerk AG & Co. KGaA (pref)'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Drägerwerk AG & Co. KGaA (pref) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Drägerwerk AG & Co. KGaA (pref) ranked by their cash flow conversion efficiency. Explore cash flow quality index of Drägerwerk AG & Co. KGaA (pref) to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Altus Group Limited
TO:AIF
0.004x
Goldsun Building Materials Co Ltd
TW:2504
0.019x
Aevis Victoria SA
SW:AEVS
0.037x
Terveystalo Oy
HE:TTALO
0.057x
Nokian Renkaat Oyj
HE:TYRES
0.015x
Playtech plc
F:PL8
0.082x
MilDef Group AB
ST:MILDEF
0.012x
BHI Co. Ltd
KQ:083650
-0.065x

Annual Cash Flow Conversion Efficiency for Drägerwerk AG & Co. KGaA (pref) (2013–2025)

The table below shows the annual cash flow conversion efficiency of Drägerwerk AG & Co. KGaA (pref) from 2013 to 2025. View Drägerwerk AG & Co. KGaA (pref) stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €1.63 Billion
≈ $1.90 Billion
€238.33 Million
≈ $278.63 Million
0.146x +34.41%
2024-12-31 €1.54 Billion
≈ $1.80 Billion
€167.31 Million
≈ $195.60 Million
0.109x -19.11%
2023-12-31 €1.41 Billion
≈ $1.65 Billion
€189.68 Million
≈ $221.75 Million
0.135x +223.13%
2022-12-31 €1.32 Billion
≈ $1.54 Billion
€-144.23 Million
≈ $-168.62 Million
-0.109x -135.80%
2021-12-31 €1.26 Billion
≈ $1.47 Billion
€384.89 Million
≈ $449.97 Million
0.305x -31.37%
2020-12-31 €1.03 Billion
≈ $1.21 Billion
€459.98 Million
≈ $537.76 Million
0.445x +191.27%
2019-12-31 €1.08 Billion
≈ $1.26 Billion
€164.42 Million
≈ $192.22 Million
0.153x +3936.11%
2018-12-31 €1.08 Billion
≈ $1.26 Billion
€4.09 Million
≈ $4.78 Million
0.004x -97.18%
2017-12-31 €1.07 Billion
≈ $1.25 Billion
€143.34 Million
≈ $167.57 Million
0.134x -31.07%
2016-12-31 €1.00 Billion
≈ $1.17 Billion
€195.32 Million
≈ $228.35 Million
0.195x +361.89%
2015-12-31 €945.93 Million
≈ $1.11 Billion
€39.86 Million
≈ $46.60 Million
0.042x -79.90%
2014-12-31 €896.61 Million
≈ $1.05 Billion
€187.98 Million
≈ $219.77 Million
0.210x +150.33%
2013-12-31 €815.97 Million
≈ $953.95 Million
€68.34 Million
≈ $79.90 Million
0.084x --

About Drägerwerk AG & Co. KGaA (pref)

F:DRW3 Germany Medical Devices
Market Cap
$1.13 Billion
€966.64 Million EUR
Market Cap Rank
#8345 Global
#1102 in Germany
Share Price
€112.40
Change (1 day)
+0.90%
52-Week Range
€62.30 - €115.20
All Time High
€115.20
About

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas m… Read more